Brief Article
Copyright ©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 28, 2014; 20(8): 2098-2106
Published online Feb 28, 2014. doi: 10.3748/wjg.v20.i8.2098
Figure 2
Figure 2 Overall survival curves. A: For patients whose hepatocellular carcinoma (HCC) tissue was positive or negative for CD133 expression. The two curves were not significantly different, based on the log-rank test (P = 0.732); B: For patients whose HCC tissue was positive or negative for CD90 expression. Survival times were significantly shorter for CD90-positive patients (P = 0.018); C: For patients whose HCC tissue was positive or negative for epithelial cell adhesion molecule (EpCAM) expression. Survival times were significantly shorter for EpCAM-positive patients (P = 0.010).